CHKP Check Point posts 206 percent Q4 2025 EPS beat shares register 064 percent gain in todays trading Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Is Springview SPHL stock stable under market conditions SPHL Latest Quarter Earnings Springview residential results lead investor focus